Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

  • Jonathan Schwartz,

Press/Media

Period20 Oct 2021

Media coverage

1

Media coverage

  • TitleRocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date20/10/21
    PersonsJonathan Schwartz,
View all 1
View less